Quarterly report · Q3

Period2023-01-21 → 2023-10-20
Filed2023-12-01
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥165.3bn2023-01-21 → 2023-10-20Cons.Net sales
Revenue¥160.1bn2022-01-21 → 2023-01-20Cons.Net sales (5-year summary)
Revenue¥124.6bn2022-01-21 → 2022-10-20Cons.Net sales
Operating income¥5.8bn2023-01-21 → 2023-10-20Cons.Operating income
Operating income¥2.3bn2022-01-21 → 2022-10-20Cons.Operating income
Ordinary income¥5.2bn2023-01-21 → 2023-10-20Cons.Ordinary income
Ordinary income¥591m2022-01-21 → 2023-01-20Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.6bn2022-01-21 → 2022-10-20Cons.Ordinary income
Profit before tax¥7.7bn2023-01-21 → 2023-10-20Cons.Income before income taxes
Profit before tax¥2.9bn2022-01-21 → 2022-10-20Cons.Income before income taxes
Net income (owners)¥4.2bn2023-01-21 → 2023-10-20Cons.Profit loss attributable to owners of parent
Net income (owners)−¥507m2022-01-21 → 2023-01-20Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥736m2022-01-21 → 2022-10-20Cons.Profit loss attributable to owners of parent
Net income¥4.5bn2023-01-21 → 2023-10-20Cons.Profit loss
Net income¥725m2022-01-21 → 2022-10-20Cons.Profit loss
Total assets¥185.6bnat 2023-10-20Cons.Assets
Total assets¥164.2bnat 2023-01-20Cons.Assets
Total assets¥167.8bnat 2022-10-20Cons.Total assets (5-year summary)
Total liabilities¥95.1bnat 2023-10-20Cons.Liabilities
Total liabilities¥80.1bnat 2023-01-20Cons.Liabilities
Net assets / equity¥90.5bnat 2023-10-20Cons.Net assets
Net assets / equity¥84.1bnat 2023-01-20Cons.Net assets
Net assets / equity¥84.1bnat 2022-10-20Cons.Net assets (5-year summary)
Cash and deposits¥32.8bnat 2023-10-20Cons.Cash and deposits
Cash and deposits¥27.2bnat 2023-01-20Cons.Cash and deposits
EPS (basic)¥266.092023-01-21 → 2023-10-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥116.782023-07-21 → 2023-10-20dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-32.42022-01-21 → 2023-01-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.992022-01-21 → 2022-10-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥102.452022-07-21 → 2022-10-20dCons.Basic earnings loss per share (5-year summary)
Equity ratio47.7%at 2023-10-20Cons.Equity to asset ratio (5-year summary)
Equity ratio50.9%at 2023-01-20Cons.Equity to asset ratio (5-year summary)
Equity ratio49.9%at 2022-10-20Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-01-21 → 2023-10-20−¥313m
Reconciling Itemsreconcilingrevenue intersegment2023-01-21 → 2023-10-20−¥313m
Reconciling Itemsreconcilingsegment profit2023-01-21 → 2023-10-20−¥1.1bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue2023-01-21 → 2023-10-20¥118.0bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2023-01-21 → 2023-10-20¥117.9bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2023-01-21 → 2023-10-20¥26m
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2023-01-21 → 2023-10-20¥4.8bn
jpcrp040300-q3r_E00424-000Dy Do Pharmareportable segmentsegment profit2023-01-21 → 2023-10-20−¥406m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue2023-01-21 → 2023-10-20¥17.1bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue external2023-01-21 → 2023-10-20¥17.1bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue intersegment2023-01-21 → 2023-10-20¥6m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentsegment profit2023-01-21 → 2023-10-20¥1.4bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue2023-01-21 → 2023-10-20¥20.6bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue external2023-01-21 → 2023-10-20¥20.6bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentsegment profit2023-01-21 → 2023-10-20¥694m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2023-01-21 → 2023-10-20¥9.9bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2023-01-21 → 2023-10-20¥9.7bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2023-01-21 → 2023-10-20¥280m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2023-01-21 → 2023-10-20¥397m
—segment totalrevenue2023-01-21 → 2023-10-20¥165.6bn
—segment totalrevenue external2023-01-21 → 2023-10-20¥165.3bn
—segment totalrevenue intersegment2023-01-21 → 2023-10-20¥313m
—segment totalsegment profit2023-01-21 → 2023-10-20¥6.8bn
Reconciling Itemsreconcilingrevenue2022-01-21 → 2022-10-20−¥521m
Reconciling Itemsreconcilingrevenue intersegment2022-01-21 → 2022-10-20−¥521m
Reconciling Itemsreconcilingsegment profit2022-01-21 → 2022-10-20−¥1.0bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥83.6bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥83.5bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2022-01-21 → 2022-10-20¥24m
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-10-20¥2.8bn
jpcrp040300-q3r_E00424-000Dy Do Pharmareportable segmentsegment profit2022-01-21 → 2022-10-20−¥380m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥16.4bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥16.4bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue intersegment2022-01-21 → 2022-10-20¥6m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentsegment profit2022-01-21 → 2022-10-20¥1.3bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥15.5bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥15.5bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-10-20−¥752m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥9.7bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥9.2bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2022-01-21 → 2022-10-20¥490m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2022-01-21 → 2022-10-20¥377m
—segment totalrevenue2022-01-21 → 2022-10-20¥125.2bn
—segment totalrevenue external2022-01-21 → 2022-10-20¥124.6bn
—segment totalrevenue intersegment2022-01-21 → 2022-10-20¥521m
—segment totalsegment profit2022-01-21 → 2022-10-20¥3.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 397
ItemContextValueUnit
Noncurrent assetsCurrentQuarterInstant85103000000JPY
AssetsPrior1YearInstant164204000000JPY
AssetsCurrentQuarterInstant185593000000JPY
Notes and accounts payable tradePrior1YearInstant20823000000JPY
Notes and accounts payable tradeCurrentQuarterInstant31013000000JPY
Short term loans payablePrior1YearInstant-JPY
Short term loans payableCurrentQuarterInstant146000000JPY
Current portion of long term loans payablePrior1YearInstant3812000000JPY
Current portion of long term loans payableCurrentQuarterInstant3769000000JPY
Accounts payable otherPrior1YearInstant12300000000JPY
Accounts payable otherCurrentQuarterInstant11812000000JPY
Income taxes payablePrior1YearInstant888000000JPY
Income taxes payableCurrentQuarterInstant3004000000JPY
Provision for bonusesPrior1YearInstant1237000000JPY
Provision for bonusesCurrentQuarterInstant2568000000JPY
Provision for directors bonusesPrior1YearInstant-JPY
Provision for directors bonusesCurrentQuarterInstant23000000JPY
Other clPrior1YearInstant4212000000JPY
Other clCurrentQuarterInstant5386000000JPY
Current liabilitiesPrior1YearInstant43275000000JPY
Current liabilitiesCurrentQuarterInstant57726000000JPY
Bonds payablePrior1YearInstant20000000000JPY
Bonds payableCurrentQuarterInstant20000000000JPY
Long term loans payablePrior1YearInstant7675000000JPY
Long term loans payableCurrentQuarterInstant7013000000JPY
Provision for directors retirement benefitsPrior1YearInstant174000000JPY
Provision for directors retirement benefitsCurrentQuarterInstant13000000JPY
Provision for share based remuneration for directors and other officers nclPrior1YearInstant164000000JPY
Provision for share based remuneration for directors and other officers nclCurrentQuarterInstant133000000JPY
Net defined benefit liabilityPrior1YearInstant346000000JPY
Net defined benefit liabilityCurrentQuarterInstant1905000000JPY
Other nclPrior1YearInstant8500000000JPY
Other nclCurrentQuarterInstant8297000000JPY
Noncurrent liabilitiesPrior1YearInstant36861000000JPY
Noncurrent liabilitiesCurrentQuarterInstant37363000000JPY
LiabilitiesPrior1YearInstant80137000000JPY
LiabilitiesCurrentQuarterInstant95089000000JPY
Capital stockPrior1YearInstant1924000000JPY
Capital stockCurrentQuarterInstant1924000000JPY
Capital surplusPrior1YearInstant374000000JPY
Capital surplusCurrentQuarterInstant1832000000JPY
Retained earningsPrior1YearInstant86717000000JPY
Retained earningsCurrentQuarterInstant89939000000JPY
Treasury stockPrior1YearInstant-4048000000JPY
Treasury stockCurrentQuarterInstant-3911000000JPY
Shareholders equityPrior1YearInstant84967000000JPY
Shareholders equityCurrentQuarterInstant89783000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant5846000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant5203000000JPY
Deferred gains or losses on hedgesPrior1YearInstant1043000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-01-20pass
balance sheet identityconsolidated 2023-10-20pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-01-20pass
statement vs summary · net assetsconsolidated 2023-10-20pass
statement vs summary · net income attributable to parentconsolidated 2022-01-21/2022-10-20pass
statement vs summary · net income attributable to parentconsolidated 2023-01-21/2023-10-20pass
statement vs summary · revenueconsolidated 2022-01-21/2022-10-20pass
statement vs summary · revenueconsolidated 2023-01-21/2023-10-20pass
statement vs summary · total assetsconsolidated 2023-01-20pass
statement vs summary · total assetsconsolidated 2023-10-20pass